RSV Prevention Trial for Pregnant Women and Newborns
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests two ways to protect babies from RSV: a vaccine given to pregnant women, and an antibody shot given to newborns. Both are already approved—this study checks if using them together works better than either alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant and between 24 and 36 weeks along.
- You are willing to receive a vaccine during pregnancy and for your baby to get an antibody shot after birth.
- You are not pregnant with twins, triplets, or more.
- You have not previously received any RSV prevention product during this pregnancy.
- You do not have a bleeding disorder or a history of severe allergic reaction to vaccines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a medicine called nirsevimab to newborns and a possible vaccine to pregnant mothers to prevent RSV, a serious lung infection in babies. It checks if combining both is safe and works better than nirsevimab alone.
This trial tests if the RSVpreF vaccine given during pregnancy can help pass antibodies to the baby in women living with HIV. It may protect the infant from RSV, a common respiratory virus.
This study asks parents in Queensland about their infant's RSV (respiratory syncytial virus) vaccination status and experiences. RSV is a common virus that can cause serious breathing problems in babies, and this research helps understand vaccination patterns.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
This study looks at how well a maternal RSV vaccine (ABRYSVO) works by using health records of babies born in Scotland. It helps determine if vaccinating pregnant people can protect newborns from severe RSV disease.
Hear when a new RSV Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.